Opening mid-June at Westfield London. Register your interest to be first to know. Email us

Psychedelic-Assisted Therapy

Novel treatment for treatment-resistant depression and other mental health conditions.

Health. Care. Convenience.

A New Frontier in Mental Health

Psychedelics - including psilocybin (magic mushrooms) and MDMA (ecstasy) - are emerging as powerful tools for treating depression, PTSD, and other mental health conditions that haven't responded to conventional treatments.

The research is compelling. A single session of psilocybin-assisted therapy can produce antidepressant effects lasting months or longer. MDMA-assisted therapy shows remarkable promise for PTSD.

We are following this research closely and working to bring these treatments to eligible clients as they become available in regulated settings.

How it works at LoveMyLife

Psychedelic-assisted therapy at LoveMyLife involves careful preparation, guided sessions, and integration support.

Assessment

Evaluation of your mental health history, symptoms, and suitability.

Guided session

Therapeutic session with a trained therapist in a controlled setting.

Integration

Follow-up sessions to process the experience and build lasting change.

Book a Consultation

Understanding Psychedelic Medicine

Psychedelic research was largely halted in the 1960s. In the last two decades, rigorous clinical trials have shown remarkable promise.

Psilocybin and MDMA remain Schedule 1 controlled drugs in the UK.

Clinical trials are happening - participants can access these treatments through research settings.

Regulatory pathways are opening: FDA breakthrough therapy designation for MDMA and psilocybin suggests they may be approved for medical use in the next few years.

We are monitoring these developments and will offer treatments as they become legally and safely available.

Currently, access is primarily through clinical trials or private treatment outside the UK.